Top Banner
Ch. 20 p. 463
50

p. 463

Feb 11, 2016

Download

Documents

Gella

p. 463. Ch. 20. AIDS and Other Immunodeficiencies. Primary: affects either adaptive or innate immunity inherited developmental Secondary: exposure to viruses and other agents Consequence: infection, life-threatening . p. 494. Severity depends on the number and type of - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: p. 463

Ch. 20

p. 463

Page 2: p. 463

Ch. 20

Ch. 20. AIDS and Other Immunodeficiencies

Primary: affects either adaptive or innate immunityinheriteddevelopmental

Secondary:exposure to viruses and other agents

Consequence: infection, life-threatening

Page 3: p. 463

Ch. 20

p. 494

Page 4: p. 463

Ch. 20

Severity depends on the number and type ofimmune system aspects involved

Earlier developmental defects are more severe

Reticular dysgenesis- cells do not differentiateduring hematopoiesis

No lymphocytes

No phagocytes

Page 5: p. 463

Ch. 20

p. 495

Page 6: p. 463

Ch. 20

SCID: Severe Combined Immunodeficiency

Lymphoid cells are depleted

Thymus does not develop

Usually fatal without intervention

Page 7: p. 463

Ch. 20

Several causes of SCID

Lack of chain of IL-2 receptoralso affects signaling through IL-4,-7,-9,-15

ADA (adenosine deaminase) deficiency

Defects in signal transduction or transcription

Deficiencies in MHC Class I or Class II synthesis

Page 8: p. 463

Ch. 20

p. 497

Page 9: p. 463

Ch. 20

Page 10: p. 463

Ch. 20

p. 496

Page 11: p. 463

Ch. 20

Specialized immunodeficiencies

Phagocytic

fewer phagocytes or reduction in function(chemotaxis, extravasation, killing)

Increased susceptibility to infectionsS. aureus, S. pneumoniae, E. coli,Pseudomonas, Candida, Aspergillus

Page 12: p. 463

Ch. 20

Neutrophil reduction

Neutropenia and worsecongenital or acquiredradiation or drugsautoimmune syndromes (e.g., SLE)can be temporaryneonatal neutropenia – Ab’s from mother

Page 13: p. 463

Ch. 20

Loss of function

LAD (leukocyte adhesion deficiency)

cells cannot adhere to endothelial cellskiller cells (CTL, NK) can’t adhere to

targetsTh and B cells can’t form conjugates

Defect in synthesis of beta-chain of integrinadhesion molecules

Lazy-leukocyte syndrome

Page 14: p. 463

Ch. 20

Killing defects

Chronic granulomatous disease (X-linked)(CGD)

Neutrophils can phagocytose bacteria but can’t kill them

Defect in oxygen metabolism; can’t produceH2O2

Page 15: p. 463

Ch. 20

Humoral deficiencies

X-linked agammaglobulinemia (XLA)first immunodeficiency defined

Pre-B cells do not progress to mature B cellsall isotypes affected

Defect in Bruton’s tyrosine kinaseheavy-chain genes are rearranged butlight chain genes are not

Page 16: p. 463

Ch. 20

Diagnosed by serum electrophoresis(gamma-globulin is severely reduced)

Treated with gamma-globulin

Still susceptible to pulmonary infections;lack of secretory IgA

Page 17: p. 463

Ch. 20

X-linked hyper-IgM

Lack of CD40L on their Th cells

CD40-CD40L interaction required for B cellresponse to T-dependent antigens

no class switching no memory cells no germinal centers in lymphoid organs

Page 18: p. 463

Ch. 20

Late-onset problems: various possible causes

Inability to switch from membrane-bound to secreted form

Structural defect in antibody

B cells do not respond to cytokines

Page 19: p. 463

Ch. 20

p. 499

Page 20: p. 463

Ch. 20

Selective IgA deficiency very common (1:600-800)

Asymptomatic or

Recurrent GI and respiratory infections

Tend to have more allergic reactions

Complement deficiencies result in either:Immunodeficiency (infections) and/or immune complex disease

Page 21: p. 463

Ch. 20

Cell-mediated deficiencies

Increased susceptibility to viral, protozoan,fungal diseases

Usually innocuous microbes can become life-threatening

Tend to affect humoral responses, too

Page 22: p. 463

Ch. 20

DiGeorge syndrome

Lack of thymus (also defects in parathyroidand aortic arches)

Diagnosis: low T cell count, no DTH, decreased T cell activity

Treatment: fetal thymus grafts

Page 23: p. 463

Ch. 20

p. 500

Page 24: p. 463

Ch. 20

p. 503

Page 25: p. 463

Ch. 20

Nude mice: no CMI

Little antibody response

Death within 6 months

Can tolerate grafts

Thymus transplants can restoreimmune competence

Page 26: p. 463

Ch. 20

To summarize, treatments for immunodeficiencies:replacement of defective element:

* missing protein* missing cell type or lineage * missing or defective gene

Page 27: p. 463

Ch. 20

Thus, pooled human gamma-globulin (Ab’s) for agammaglobulinemia

Recombinant gamma-interferon for CGDRecombinant IL-2 for AIDS patientsRecombinant ADA for ADA-deficient SCID patients

Gene therapy for ADA-deficiency and CGD, p67phox-deficiency: CD34+ stem cells from pt. transfected with normal copy of defective gene)

Cell replacement: bone marrow transplantation CD34+ stem cells from HLA-matched donor

Page 28: p. 463

Ch. 20

SCID mice- autosomal recessive mutationno B or T cells, other cells functionalcan be cured with bone marrow transplant

RAG knockout mice have also been developed

Knockout mice can be “designed” with specificimmune deficiencies

SCID-hu mouse is engrafted with human fetal liver,adult thymus and lymph nodes

Page 29: p. 463

Ch. 20

SCID-hu Mice – discussed on p. 504

Page 30: p. 463

Ch. 20

Secondary immunodeficiencies

Acquired hypogammaglobulinemia

Immune suppressionAgent-induced immunodeficiency

AIDS, caused by HIV-1 retrovirus

Page 31: p. 463

Ch. 20

p. 505

Page 32: p. 463

Ch. 20

p. 506

Page 33: p. 463

Ch. 20p. 508

Page 34: p. 463

Ch. 20

Page 35: p. 463

Ch. 20

p. 509

Page 36: p. 463

Ch. 20

p. 510

Page 37: p. 463

Ch. 20

Page 38: p. 463

Ch. 20

p. 511

Page 39: p. 463

Ch. 20

Page 40: p. 463

Ch. 20

Page 41: p. 463

Ch. 20

p. 512

Page 42: p. 463

Ch. 20

p. 513

Page 43: p. 463

Ch. 20 p. 516

Page 44: p. 463

Ch. 20

Page 45: p. 463

Ch. 20p. 515

Page 46: p. 463

Ch. 20

p. 516

Page 47: p. 463

Ch. 20

Categories of drugs – p. 517

Reverse transcriptase inhibitorsnucleoside analogsnonnucleoside analogs

Protease inhibitors

Fusion inhibitor

Lots of drugs, lots of side effects

Combinations lower viral load

Page 48: p. 463

Ch. 20

p. 517

Page 49: p. 463

Ch. 20

p. 519

Page 50: p. 463

Ch. 20

Summary

Immune deficiencies are either primary(genetic, developmental)

Or acquired (infection, radiation, HIV, immunosuppressive treatment)

Classified by type of cell(s) compromised

Treatments:replacement: bone marrow, gene therapyless extreme: antibody therapy, drugs